Flot.bio hat dies direkt geteilt
"What makes it unique is the chemistry…It has a specific spiking pattern that stands for low toxicity." Here's a short clip from our chat with Dr. Claudia Ulbrich. Discover how Cardior Pharmaceuticals was one of the first to make microRNA (miRNA)-targeted therapeutics work for cardiac diseases. “I think in the first instance, there was a different approach to identify the right microRNA.” Learn about how the science works and the outcomes for patients. "We are reducing the target with more than 50-55%…” What do you think about this form of therapeutics?